214 Yasumaru Hatanaka et al.
Synthesis of 2-(fluoronitrophenoxy)ethyl methanethiosulfonate
(1). 2-(2-Fluoro-4-nitrophenoxy)ethyl chloride (2.20 g, 10 mmol) and
sodium methanethiosulfonate (4.02 g, 30 mmol) were dissolved in
10 mL DMF and the mixture was stirred at 120ꢁC for 1.5 h. To the
mixture was added 100 mL benzene, and the precipitate was removed by
filtration. After removal of solvent, the product was purified by
chromatography on silica gel eluted with benzene. Recrystallization
from benzene resulted 2-(2-fluoro-4-nitrophenoxy)ethyl methanethio-
sulfonate (1a) as colorless leaflets, 1.78 g (60%). M.p. 122–123ꢁC. IR
(nujor)1600 cm)1. 1H NMR(CDCl3) d 7.7–8.2(m, 2H), 7.0–7.1(m, 1H),
4.47 (t, 2H, J = 6 Hz) and 3.44 (s, 3H). MS m ⁄ z 295 (M+). Anal. Calcd.
for C9H10FNO5S2:C, 36.61;H, 3.41; F, 4.74; N, 6.43; S, 21.71. Found:C,
36.56; H, 3.37; F, 4.74; N, 6.46; S, 21.91. 2-(4-fluoro-2-nitrophen-
oxy)ethyl methanethiosulfonate (1b) was similarly prepared from
2-(4-fluoro-2-nitrophenoxy)ethyl chloride (3.14 g, 20 mmol). Recrys-
tallization from ether yielded colorless leaflets, 3.8 g (65%). M.p. 45–
46ꢁC. IR (nujor) 1590 cm)1. 1H NMR (CDCl3) d 7.61 (dd, 1H, J = 3,
8 Hz), 7.30 (ddd, 1H, J = 3, 8, 9 Hz), 7.12 (dd, 1H, J = 4, 9 Hz), 4.43
(t, 2H, J = 6 Hz), 3.57 (t, 2H, J = 6 Hz) and 3.40 (s, 3H). MS m ⁄ z 295
(M+). Anal. Calcd. for C9H10FNO5S2: C, 36.61; H, 3.41; F, 4.74; N, 6.43;
S, 21.71. Found: C, 36.54; H, 3.50; F, 4.79, N, 6.49; S, 21.77.
Preparation of photoreactive GAPDH. Before modification, rabbit-
muscle GAPDH was treated with charcoal (Sigma–Aldrich, USA) to
remove NAD+ according to the literature (11). To 0.1 M Tris buffer
(pH 8.5, 21 mL) containing the resulting apo-enzyme was added
2-(2-fluoro-4-nitrophenoxy)ethyl methanethiosulfonate (1a) or 2-(4-
fluoro-2-nitrophenoxy)ethyl methanethiosulfonate (1b) (660 lM in
DMSO), and the mixture was stirred at 4ꢁC for 30 min in the dark
to give GAPDH-a and GAPDH-b, respectively. The reaction mixture
was subjected to a gel filtration on Sephadex G-25 (1.15 · 30 cm,
pyrophosphate pH 8.5, 0.1 mM EDTA, 4ꢁC) to remove the excess
reagents. The GAPDH fractions were collected by monitoring of
absorption at 280 nm and used for the photolabeling experiments.
Photolysis of modified GAPDH and determination of labeling
efficiency. A solution of GAPDH-a or GAPDH-b in 10 mM
pyrophosphate buffer (pH 8.5) containing 0.1 mM EDTA was
irradiated with a 100 W black-ray lamp for 2 h at 0ꢁC. To determine
the efficiency of photo-affinity labeling, 50 mM pyrophosphate
buffer (pH 8.5, 0.8 mL) and 2-mercaptomethanol (1 lL) were added
to a photolabeled GAPDH sample solution (0.2 mL) followed by
incubation for 12 h at 20ꢁC. After ultrafiltration through Centricon
10 (Amicon) at 5000 g for 60 min, UV–vis spectra of the filtrates
were measured and the efficiencies were calculated from the
absorptions at 400 nm for GAPDH-a and 420 nm for GAPDH-b,
respectively.
Treatment of photoproducts with cyanogen bromide. After photoly-
sis of GAPDH-a, the sample solution (40 mL) containing urea
(19.6 g, 8 M), EDTA (84 mg, 0.2%) and 2-mercaptomethanol
(64 lL, 0.9 mmol) was added. The solution was adjusted to pH 8.2
by sodium hydroxide, and incubated at 20ꢁC for 4 h. After
incubation with iodoacetic acid (166 mg, 0.8 mmol) at 20ꢁC for
1 h, the mixture was dialyzed in water and then concentrated
in vacuo. The sample was dissolved in 70% formic acid (27 mL)
followed by the addition of cyanogen bromide (95 mg, 0.9 mmol).
The mixture was incubated at 20ꢁC for 24 h under argon. To the
solution was added water (30 mL) and concentrated to 2 mL
in vacuo. This procedure was repeated thrice. The solution was
centrifuged and the pellet was dissolved in formic acid (1 mL) and
combined with the supernatant. The sample solution was loaded on a
Chemcosorb 7C18 column (10 · 300 mm, Chemco) which was pre-
equilibrated with 26% acetonitrile containing 0.1% trifluoroacetic
acid and developed with a linear gradient of acetonitrile consisting of
26–58% over 60 min at flow rate of 2 mL ⁄ min. Fractions were
monitored by measuring the absorbance at 215 and 380 nm. The
main peak fractions were pooled and the solvents were evaporated to
1 mL in vacuo. The sample was chromatographed on l Bondapak
C18 (10 · 300 mm, Waters) which had been pre-equilibrated with
0.1% trifluoroacetic acid containing 18% acetonitrile-2-propanol (3 :
7, v ⁄ v), followed by a linear gradient of 18–82% acetonitrile-2-
propanol (3 : 7, v ⁄ v) over 30 min at a flow rate of 1 mL ⁄ min.
Fractions were monitored by measuring the absorbance at 215 and
380 nm. The main peak fractions were pooled and the solvents were
evaporated in vacuo. Treatment of GAPDH-b and isolation of the
labeled peptides were similarly performed.
V8 protease digestion of photoproducts. The isolated peptides after
cyanogen bromide treatment were digested with V8 protease
(1 mg ⁄ mL, 200 lL, 7.2 nmol) in 100 mM sodium phosphate buffer
(pH 7.8, 20 mL) at 37ꢁC for 12 h followed by continuous incubation
for 36 h after addition of the same amount of V8 protease. The
solution was concentrated to 0.5 mL in vacuo. The solution was
centrifuged and the pellet was dissolved in formic acid (0.3 mL) and
combined with the supernatant. The sample was chromatographed on
micron Bondapak C18 (10 · 300 mm, Waters) which had been pre-
equilibrated with 18% 2-propanol-acetonitrile (7 : 3, v ⁄ v) containing
0.1% trifluoroacetic acid, followed by a linear gradient of 18–50%
2-propanol-acetonitrile (7 : 3, v ⁄ v) over 30 min at a flow rate of
1 mL ⁄ min. Fractions were monitored by measuring the absorbance at
215 and 380 nm. The main peak fractions were pooled and the solvents
were evaporated to 1 mL in vacuo. The solution was centrifuged and
the pellet was dissolved in formic acid (0.5 mL) and combined with the
supernatant. The sample solution was loaded on a Chemcosorb 7C18
column (4.6 · 250 mm, Chemco) which was pre-equilibrated with 20%
acetonitrile containing 0.1% trifluoroacetic acid and developed with
20% acetonitrile containing 0.1% trifluoroacetic acid at flow rate of
1 mL ⁄ min. After removal of the solvent, the residue was dissolved in
70% formic acid for amino acid sequence analysis. Treatment of
GAPDH-b and purification of the labeled peptides were similarly
performed.
Photoreaction of fluoronitroanisoles and N-acetyllysinamide.
2-Fluoro-4-nitroanisole (2a, 171 mg, 1 mmol) and N-acetyllysinamide
(187 mg, 1 mmol) was dissolved in a mixed solvent (20 mL) of 50%
(v ⁄ v) acetonitrile and 0.1 M aqueous sodium hydrogen carbonate. The
solution was irradiated with a 100 W black-ray lamp for 5 h under
nitrogen. After removal of the solvent, the product was chromato-
graphed on silica gel (chloroform : methanol = 20 : 1) followed by
recrystallization from ethyl acetate to give N-acetyl-N¢-(2-methoxy-
5-nitrophenyl)lysinamide (3a) as yellow needles (12 mg, 4%). M.p.
184–185ꢁC. IR (nujor) 3320, 3200, 1700, 1680 cm)1. 1H NMR (CDCl3)
d 7.62 (dd, 1H, J = 3, 9 Hz), 7.34 (d, 1H, J = 3 Hz), 6.74 (d, 1H,
J = 9 Hz), 6.07 (br s, 2H), 5.39 (br s, 1H), 4.48 (dt, 2H, J = 7, 7 Hz),
4.39 (br s, 1H), 3.94 (s, 3H), 3.21 (dt, 2H, J = 7, 7 Hz), 2.03 (s, 3H)
and 1.4–2.0 (m, 6H). MS m ⁄ z 388 (M+). HRMS m ⁄ z calcd. for
C15H22N4O5: 388.1592. Found: 338.1602. 2-Methoxy-5-nitrophenol
(21 mg, 12%) was also given in the reaction and 2a (137 mg, 80%) was
recovered. The photoreaction of 4-fluoro-2-nitroanisole (2b) for 10 h
gave N-acetyl-N¢-(4-methoxy-3-nitrophenyl)lysinamide (3b) as orange
needles after recrystallization from ethyl acetate (26 mg, 8%). M.p.
132–133ꢁC. IR (nujor) 3350, 3200, 1700, 1675 cm)1. 1H NMR (CDCl3)
d 7.05 (d, 1H, J = 3 Hz), 6.94 (d, 1H, J = 9 Hz), 6.78 (dd, 1H,
J = 3, 9 Hz), 6.09 (br s, 2H), 5.42 (br s, 1H), 4.51 (dt, 2H, J = 7,
7 Hz), 3.88 (s, 3H), 3.72 (br s, 1H), 3.12 (t, 2H, J = 7 Hz), 2.03 (s, 3H)
and 1.4–2.0 (m, 6H). MS m ⁄ z 388 (M+). HRMS m ⁄ z Calcd. for
C15H22N4O5: 388.1592. Found: 338.1602. 4-Methoxy-3-nitrophenol
(31 mg, 18%) was also given in the reaction and 2b (116 mg, 67%) was
recovered.
RESULTS AND DISCUSSION
Preparation of photoreactive GAPDH
GAPDH is a homo-tetramer protein and each subunit has an
active site containing an un-oxidized sulfhydryl group of
Cys149 used for catalytic reaction. It catalyzes the oxidation of
glyceraldehyde-3-phosphate to form 1,3-diphosphoglycerate
with the concomitant reduction of b-nicotinamide adenine
dinucleotide (NAD+) (8–10). The chemical labeling of the
rabbit-muscle GAPDH active site with thermally reactive
probes suggested that the ꢀ-amino group of Lys183 could be
near to catalytic SH because it was acetylated through the
migration of acetyl Cys149 (15) from S to N atom and this
observation was confirmed by a cross-linking reagent (16). The
X-ray structure of rabbit-muscle GAPDH was recently repor-
ted (11), and the catalytic center was revealed as the first
detailed model of mammalian GAPDH. There are several